SmithKline Beecham
This article was originally published in The Rose Sheet
Executive Summary
Jean-Pierre Garnier succeeds Jan Leschly as CEO April 28; Garnier also is set to become CEO of Glaxo SmithKline following the merger of SB and Glaxo-Wellcome. Garnier, 52, joined SmithKline in 1990 as president of the company's North America pharmaceutical business and took over worldwide operations in 1994. He became chief operating officer in 1995. Leschly retires after serving as SmithKline CEO since 1994. During the pair's collaboration, SB's consumer healthcare division became the second largest worldwide